The Amplatzer™ Septal Occluder is a percutaneous, transcatheter, atrial septal defect closure device intended for the occlusion of atrial septal defects (ASD) in secundum position or …

The AMPLATZER PFO Occluder fically designed to stop blood flow through all types of PFO (Figure 3). The device is placed in the PFO

The addition of the Amplatzer Multifenestrated Septal Occluder - “Cribriform” to the Amplatzer family of occluders enables transcatheter closure for the majority of atrial septal defects.

Abbott’s Amplatzer Septal Occluder is a gold standard for atrial septal defects (ASD) treatment in percutaneous, transcatheter closure.

Dec 19, 2025 · The Amplatzer Piccolo Occluder received FDA approval and CE Mark in 2019. “We designed the Amplatzer Piccolo Delivery System based on feedback from leading …

Jul 21, 2023 · For 25 years, these devices have been helping treat congenital heart defects and reduce the risk of stroke, from our Amplatzer Amulet LAA Occluder to our smaller-than-a-pea …

This study supports the safety and effectiveness of the Amplatzer Piccolo Occluder, particularly in patients between 700 g and 2 kg where there is currently a significant unmet need in the …

Over 25 years ago, we pioneered PFO closure with the Amplatzer™ PFO Occluder. Today, it is the most-studied — and most-trusted — device of its kind, with over 180,000 patients treated …

The Amplatzer™ Talisman™ PFO Occluder is built off the device that created the category, sustained leadership over decades of use, and was the first device supported by positive trials …

The AMPLATZER PFO Occluder is a percutaneous, transcatheter occlusion device intended for the non-surgical closure of patent foramen ovale in subjects who have had a cryptogenic …